Literature DB >> 20118279

Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease.

Ashley D Reynolds1, David K Stone, Jessica A L Hutter, Eric J Benner, R Lee Mosley, Howard E Gendelman.   

Abstract

Nitrated alpha-synuclein (N-alpha-syn) immunization elicits adaptive immune responses to novel antigenic epitopes that exacerbate neuroinflammation and nigrostriatal degeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of Parkinson's disease. We show that such neuroimmune degenerative activities, in significant measure, are Th17 cell-mediated, with CD4(+)CD25(+) regulatory T cell (Treg) dysfunction seen among populations of N-alpha-syn-induced T cells. In contrast, purified vasoactive intestinal peptide induced and natural Tregs reversed N-alpha-syn T cell nigrostriatal degeneration. Combinations of adoptively transferred N-alpha-syn and vasoactive intestinal peptide immunocytes or natural Tregs administered to MPTP mice attenuated microglial inflammatory responses and led to robust nigrostriatal protection. Taken together, these results demonstrate Treg control of N-alpha-syn-induced neurodestructive immunity and, as such, provide a sound rationale for future Parkinson's disease immunization strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20118279      PMCID: PMC2824790          DOI: 10.4049/jimmunol.0901852

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

Review 1.  Immunological decision-making: how does the immune system decide to mount a helper T-cell response?

Authors:  Gerard E Kaiko; Jay C Horvat; Kenneth W Beagley; Philip M Hansbro
Journal:  Immunology       Date:  2007-11-05       Impact factor: 7.397

2.  Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration.

Authors:  Jianuo Liu; Nan Gong; Xiuyan Huang; Ashley D Reynolds; R Lee Mosley; Howard E Gendelman
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

3.  IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells.

Authors:  Thomas Korn; Meike Mitsdoerffer; Andrew L Croxford; Amit Awasthi; Valérie A Dardalhon; George Galileos; Patrick Vollmar; Gretta L Stritesky; Mark H Kaplan; Ari Waisman; Vijay K Kuchroo; Mohamed Oukka
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-17       Impact factor: 11.205

4.  Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets.

Authors:  Ashley D Reynolds; David K Stone; R Lee Mosley; Howard E Gendelman
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

5.  Interplay between effector Th17 and regulatory T cells.

Authors:  Amit Awasthi; Gopal Murugaiyan; Vijay K Kuchroo
Journal:  J Clin Immunol       Date:  2008-09-23       Impact factor: 8.317

6.  The promise and perils of an Alzheimer disease vaccine: a video debate.

Authors:  Dave Morgan; Gary Landreth; Paula Bickford
Journal:  J Neuroimmune Pharmacol       Date:  2009-03       Impact factor: 4.147

7.  Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease.

Authors:  Shaji Theodore; Shuwen Cao; Pamela J McLean; David G Standaert
Journal:  J Neuropathol Exp Neurol       Date:  2008-12       Impact factor: 3.685

8.  Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.

Authors:  J Michael Gee; Angela Kalil; Matthew Thullbery; Kyra J Becker
Journal:  Stroke       Date:  2008-03-06       Impact factor: 7.914

9.  Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.

Authors:  Eric J Benner; Rebecca Banerjee; Ashley D Reynolds; Simon Sherman; Vladimir M Pisarev; Vladislav Tsiperson; Craig Nemachek; Pawel Ciborowski; Serge Przedborski; R Lee Mosley; Howard E Gendelman
Journal:  PLoS One       Date:  2008-01-02       Impact factor: 3.240

10.  Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.

Authors:  Rebecca Banerjee; R Lee Mosley; Ashley D Reynolds; Alok Dhar; Vernice Jackson-Lewis; Paul H Gordon; Serge Przedborski; Howard E Gendelman
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

View more
  142 in total

Review 1.  Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.

Authors:  Mario Delgado; Doina Ganea
Journal:  Amino Acids       Date:  2011-12-03       Impact factor: 3.520

Review 2.  Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases.

Authors:  Lisa M Kosloski; Duy M Ha; Jessica A L Hutter; David K Stone; Michael R Pichler; Ashley D Reynolds; Howard E Gendelman; R Lee Mosley
Journal:  J Neurochem       Date:  2010-05-26       Impact factor: 5.372

3.  A model of nitric oxide induced α-synuclein misfolding in Parkinson's disease.

Authors:  David K Stone; Tomomi Kiyota; R Lee Mosley; Howard E Gendelman
Journal:  Neurosci Lett       Date:  2012-07-07       Impact factor: 3.046

Review 4.  Immune-mediated processes in neurodegeneration: where do we stand?

Authors:  Marc Fakhoury
Journal:  J Neurol       Date:  2016-02-12       Impact factor: 4.849

Review 5.  Bridge between neuroimmunity and traumatic brain injury.

Authors:  Matthew L Kelso; Howard E Gendelman
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 6.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 7.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

8.  GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice.

Authors:  Lisa M Kosloski; Elizabeth A Kosmacek; Katherine E Olson; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2013-10-29       Impact factor: 3.478

9.  Glia maturation factor deficiency suppresses 1-methyl-4-phenylpyridinium-induced oxidative stress in astrocytes.

Authors:  Mohammad Moshahid Khan; Duraisamy Kempuraj; Smita Zaheer; Asgar Zaheer
Journal:  J Mol Neurosci       Date:  2014-01-16       Impact factor: 3.444

Review 10.  Innate and adaptive immune responses in Parkinson's disease.

Authors:  Aubrey M Schonhoff; Gregory P Williams; Zachary D Wallen; David G Standaert; Ashley S Harms
Journal:  Prog Brain Res       Date:  2019-12-05       Impact factor: 2.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.